A clinical trial to study the efficacy of Gabapentin as premedication for patients undergoing cataract surgeries under local anesthesia

Oral Gabapentin premedication for elderly patients undergoing Intraocular surgery

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2010/091/003011

Enrollment

Registered

2010-12-20

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Elderly ASA I, II, III Intraocular surgeries

Interventions

Intervention1: Gabapentin: 600mg orally half an hour before surgery Control Intervention1: Diazepam: 10mg orally half an hour before surgery

Eligibility

Inclusion criteria

Inclusion criteria: ASA I and II patients Elective intraocular surgery under local anesthesia

Exclusion criteria

Exclusion criteria: History Bronchial asthma, Renal impairment History of coronary artery disease Patients taking Calcium channel blockers Intraocular pressure more than 24mm hg preoperatively

Design outcomes

Primary

Measure	Time frame
Anxiety scoresTimepoint: 4 hours;Anxiety scoresTimepoint: 4 hours;Anxiety scoresTimepoint: 4 hours	—

Secondary

Measure	Time frame
Intraocular pressureTimepoint: 1 hour	—

Countries

India

Contacts

Public ContactDrSatyen Parida

drkarunya@gmail.com8143769301

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026